The contraceptive choice at the time of a surgical and pharmacological abortion: a possible and effective option thanks to a dedicate counselling

Abstract

The percentage of repeat abortion in Italy is about 25%. It is therefore important to implement the strategies that can facilitate the adoption of the most effective contraceptive methods. Long-acting reversible contraceptive methods are currently considered the most effective and with the highest rates of 12-months continuation, with a reported reduction of recurrent abortion. Our study has the aim to evaluate the contraceptive choice of women requesting abortion, when an accurate and dedicate counselling is offered and the availability of a LARC method is given immediately after pregnancy termination, both in case of surgical and medical abortion. LARC methods were chosen both in case of surgical and medical abortion, by an high percentage of patients. We reported no differences between the surgical and pharmacological groups on the choice of LARC and SARC. Our observational study shows the feasibility to perform an accurate, dedicate, and personalised counselling on contraception at time of abortion. This approach has enabled a high number of women to have a LARC method inserted at the time of abortion, as a valid strategy to prevent the risk unplanned pregnancy.

Condensation

Repeated abortion is an international problem which could be reduced by LARCs methods use. Contraceptive counselling during hospitalisation for abortion could implement the use of LARC.

摘要

意大利重复流产的比例约为25%。因此, 最高效避孕方法策略的实施很重要。长效可逆避孕方法目前被认为是最有效的, 12个月持续避孕率最高, 据报道反复流产减少。我们的研究旨在评估要求流产妇女的避孕选择, 在手术和药物流产立即终止妊娠后, 为其提供准确和专业的咨询及长效可逆避孕（LARC）方法的选择。在手术流产和药物流产的情况下, 选择LARC方法的患者比例很高。我们的报告手术组和药物组在选择LARC和SARC方面没有差异。我们的观察性研究表明, 在流产时进行准确、专业和个性化的避孕咨询是可行的。这种方法使许多妇女能够在堕胎时植入LARC, 作为预防意外怀孕的有效策略。

总结

反复流产是一个国际性问题, 可以通过应用LARCs来减少。流产住院期间进行避孕咨询可以促进LARC的应用。

Keywords:

• Abortion
• contraception
• long-acting reversible methods
• lARC

Disclosure statement

No potential conflict of interest was reported by the author.